Ketamine blocks morphine-induced conditioned place preference and anxiety-like behaviors in mice
Greer McKendrick, Hannah Garrett, Holly E. Jones, Dillon S. McDevitt, Sonakshi Sharma, Yuval Silberman, Nicholas M. Graziane
bioRxiv Preprint Server January 22, 2020 preprint DOI: 10.1101/2020.01.22.915728 via bioRxiv
Summary
AI-generated from the abstractMice conditioned with morphine showed anxiety-like behavior (less time in the open arms of an elevated plus maze) and robust conditioned place preference (CPP) for morphine. A single dose of (R,S)-ketamine given before testing increased open-arm time in both morphine- and saline-conditioned mice. A second ketamine injection before CPP tests blocked morphine-induced CPP, an effect lasting up to 28 days. Sucrose conditioning did not evoke anxiety but produced CPP, which ketamine also attenuated. These results suggest ketamine's blockade of morphine CPP may stem from impairing drug-context memory rather than solely reducing negative affective states.
Study at a glance
| Characteristics | Experimental study |
|---|---|
| Population | Mice |
| Interventions | Morphine (R S)-ketamine |
| Dose | 10 mg/kg |
| Duration | 5-day conditioning, tests on post-conditioning days 1 and 2, with a 28-day follow-up for place preference |
| Topics | Anxiety Ketamine |
| Keywords | Opioid addiction Drug memory |
| Citations | 1 |
| Key finding | Ketamine treatment blocked morphine-induced conditioned place preference in mice, an effect that persisted for up to 28 days, suggesting the blockade may involve impaired memory of morphine-context associations rather than just alleviation of anxiety. |
Abstract
Patients suffering from opioid use disorder often relapse during periods of abstinence, which is posited to be caused by negative affective states that drive motivated behaviors. Here, we explored whether conditioning mice with morphine in a CPP training paradigm evoked anxietylike behavior during morphine abstinence. To do this, mice were conditioned with morphine (10 mg/kg, i.p.) for five days. 24 h following conditioning, anxiety levels were tested by measuring time in the open arms of the elevated plus maze. The next day, mice were placed in the three compartment chamber to measure morphine-induced conditioned place preference (CPP). Our results show that following morphine conditioning, mice spent significantly less time in the open arm of the elevated plus maze and expressed robust morphine CPP on CPP test day. Furthermore, we found that an acute treatment with (R,S)-ketamine (10 mg/kg, i.p.), a medication demonstrating promise for preventing anxiety-related phenotypes, 30 min. prior to testing on post conditioning day 1, increased time spent in the open arm of the elevated plus maze in saline- and morphine-conditioned mice. Additionally, we found that a second injection of ketamine 30 min. prior to CPP tests on post conditioning day 2 prevented morphine-induced CPP, which lasted for up to 28 d post conditioning. Furthermore, we found that conditioning mice with 10% (w/v) sucrose using an oral self-administration procedure did not evoke anxietylike behavior, but elicited robust CPP, which was attenuated by ketamine treatment 30 min. prior to CPP tests. Overall, our results suggest that the ketamine-induced block of morphine CPP may not be attributed solely to alleviating negative affective states, but potentially through impaired memory of morphine-context associations.